Skip to main content
Clinical Trials/NCT02725710
NCT02725710
Completed
Phase 2

Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration: a Randomized Controlled Trial

Duke University1 site in 1 country96 target enrollmentAugust 2016

Overview

Phase
Phase 2
Intervention
Placebo
Conditions
Other Abortion
Sponsor
Duke University
Enrollment
96
Locations
1
Primary Endpoint
Pain Score on 100-mm VAS (Visual Analog Scale) at 5 Minutes Post-procedure
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This is a randomized controlled double-blind placebo-controlled trial evaluating the impact of gabapentin given preoperatively on perioperative pain scores for women receiving uterine aspiration between 6 and 14+6 weeks gestation. This study will be a trial included in a prospective meta-analysis evaluating the use of gabapentin on perioperative pain in the abortion setting.

Registry
clinicaltrials.gov
Start Date
August 2016
End Date
June 14, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Women \>=18 years-old
  • Presenting for a surgical abortion
  • No contraindication to outpatient abortion
  • No contraindication to gabapentin
  • Fluency in English and able to provide informed consent

Exclusion Criteria

  • Allergy, sensitivity or contraindication to gabapentin
  • Severe renal disease
  • Currently using gabapentin or pregalabin

Arms & Interventions

Group 1: Placebo

Usual perioperative pain management protocol PLUS placebo orally 1-2 hour prior to procedure.

Intervention: Placebo

Group 2: Gabapentin

Usual perioperative pain management protocol PLUS 600mg Gabapentin administered orally 1-2 hour prior to procedure.

Intervention: Gabapentin

Outcomes

Primary Outcomes

Pain Score on 100-mm VAS (Visual Analog Scale) at 5 Minutes Post-procedure

Time Frame: 5 minutes

Score range of 0 to 100, where 0 means no pain and 100 means worst pain in my life.

Secondary Outcomes

  • Number of Subjects Experiencing Perioperative Vomiting(Baseline (pre-operatively immediately prior to the procedure), 10 minutes, 30 minutes)
  • Side Effects (on a 5-point Scale)(Post-operative day 1)
  • Perioperative Anxiety as Measured by the 100-mm VAS(5 minutes, 10 minutes, 30 minutes, discharge)
  • Number of Subjects Using Pain Medications(24 hours post-operatively)
  • Nausea (on a 5-point Scale)(Post-operative day 1)
  • Pain Score on the 100-mm VAS(Baseline (pre-operatively immediately prior to the procedure), 10 minutes, 30 minute)
  • Perioperative Nausea as Measured by 100-mm VAS(Baseline (pre-operatively immediately prior to the procedure), 10 minutes, 30 minutes)
  • Number of Subjects Experiencing Side Effects(10 minutes post-procedure)
  • Pain (on a 5-point Scale)(Post-operative day 1)
  • Vomiting (on a 5-point Scale)(Post-operative day 1)
  • General Satisfaction With the Procedure (on a 5-point Scale)(Post-operative day 1)

Study Sites (1)

Loading locations...

Similar Trials